Location permission needed for a better experience.
How can we help you?
CV
MEMBERSHIPS
PUBLICATIONS
EDUCATION
  • 2003 Hacettepe Üniversitesi Tıp Fakültesi Tıbbi Onkoloji
  • 1999 Hacettepe Üniversitesi Tıp Fakültesi İç Hastalıkları
  • 1994 Hacettepe Üniversitesi Tıp Fakültesi
EXPERIENCE
  • 2022 Acıbadem Sağlık Grubu
  • 2021 Şişli Hamidiye Etfal Eğitim ve Araştırma Hastanesi / Prof. Dr.
  • 2012 - 2021 Zonguldak Bülent Ecevit Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Tıbbi Onkoloji Bilim Dalı / Prof. Dr.
  • 2006 - 2012 Zonguldak Bülent Ecevit Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Tıbbi Onkoloji Bilim Dalı / Doç. Dr.
  • 2004 - 2006 Zonguldak Bülent Ecevit Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Tıbbi Onkoloji Bilim Dalı / Yrd. Doç. Dr.
  • 2004 Özel Zonguldak A Tıp Merkezi, Zonguldak / Uzman Doktor
  • 2003 Burhan Nalbantoğlu Devlet Hastanesi, Lefkoşa, KKTC / Uzman Doktor
  • 1999 - 2003 Hacettepe Üniversitesi Tıp Fakültesi / İç Hastalıkları Anabilim Dalı / Tıbbi Onkoloji Bilim Dalı / Yandal asistanı
  • 1999 - 2003 Tümör Biyolojisi ve İmmünolojisi MSc Degree Programı, Hacettepe Üniversitesi Onkoloji Enstitüsü, Temel Onkoloji Bilim Dalı / Özel Öğrenci
  • 1994 - 1999 Hacettepe Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı / Arş. Gör. Dr.
MEMBERSHIPS
  • Türk Onkoloji Grubu Flims Alumni Club (FAC)
  • ESMO (European Society for Medical Oncology)
  • Türk İç Hastalıkları Uzmanlık Derneği
  • Tıbbi Onkoloji Derneği
PUBLICATIONS
  • Intraoperative Ultrasonography-Guided Surgery; An effective modality for breast conservation after neo-adjuvant ehemotherapy Breast Journal. 2020;26:1680-1687 Taşdöven İ, Çakmak GK, Emre AU, Engin H. Bahadır B, Bakkal BH, Güllüoğlu MB.
  • Serum Sulphate Levels in Hemodialysis Patients Int J Nephrol. 2019 Dec 1;2019:1063514. doi: 10.1155/2019/1063514. eCollection 2019 Yildirim I, Hur E, Magden K, İlikhan S, Engin H, Can M, Yıldız G, Özer İ.
  • Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a retrospeetive analysis Urun Y. J BUON. 2018 Dec;23(7): 116-121. Ergun Y, Ozdemir NY, Guner EK, Esin E, Sendur MA, Koksoy EB, Demirci NS, Eren T, Dede I, Sezer A, Engin H, Oksuzoglu B, Yalcin B, Utkan G, Zengin N,
  • The effects of zoledronic acid on ECG: a prospeetive study on patients with bone metastatic cancer Clin Cases Miner Bone Metab. 2017 Jan-Apr; 14(1):35-39. doi: 10.11138/ccmbm/2017.14.1.035. Epub 2017 May 30. Demirtas D, Bilir C, Demirtas AO, Engin H.
  • Efficacv of metronomic vinorelbine in elderly patients with advanced non-small-cell lung cancer and poor performance status Curr Oncol. 2017 Jun;24(3):el99-e204. doi: 10.3747/co.24.3486. Epub 2017 Jun 27. Bilir C, Durak S, Kızılkaya B, Hacıbekiroglu I, Nayır E, Engin H.
  • Prognostic value of total lesion glycolysis in stage IIIB/IV nonesmall celi lung cancer. Journal of Oncological Sciences 3 (2017) 107-11 Yusufoğlu B, Bilir C, Engin H.
  • Leptin ve Leptin Reseptörü Gen Varyantları ile Kolorektal Kanser Arasındaki İlişki Üzerine Bir Çalışma. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi. 2017;4(1): 10-14. Korkmaz N, Kimyon AS, Ermiş E, Edgünlü T, Arpacı E, Engin H. Karakaş Çelik S.
  • Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Celi Carcinoma: A Turkish Oncology Group (TOG) Study Clin Genitourin Cancer. 2016 Aug; 14(4):e347-53. Artaç M, Çoşkun HŞ, Korkmaz L, Koçer M, Turhal IMS, Engin H. Dede İ, Paydaş S, Öksüzoğlu B, Bozcuk H, Demirkazık A.
  • 10. Red Celi Distribution Width Has a Predictable Value for Differentiation of Provoked and Unprovoked Venous Thromboembolism Indian J Hematol Blood Transfus. 2016 Dec;32(4):481-487. Ertop S, Bilici M, Engin H, Buyukuysal C, Arslaner M, Toka B, Tekin
  • Increased serum tumor necrosis factor receptor-associated factor-6 expression in patients vvith non- metastatic triple-negative breast cancer Oncol Lett. 2015 Jun;9(6):2819-2824. Bilir C, Engin H, Can M, Likhan S, Demirtas D, Kuzu F, Bayraktaroglu T.

INFORMATION FORM WITH REGARD TO OBTAINING AND PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. (“Acıbadem”) and Acıbadem’s controlling shareholders, parent companies and affiliates (hereinafter to be collectively referred to as “Acıbadem Group”) may, acting as “Data Supervisor” under the Law on Protection of Personal Data no. 6698 (the “Law”) and other pertinent laws and regulations, process your personal data within the following frame and in strict compliance with the Basic Healthcare Services Law no. 3359, the Governmental Decree-Law on Organization and Duties of the Ministry of Health and its Affiliated Companies no. 663, the Private Hospitals Regulation, and other regulations of the Ministry of Health, and other applicable laws and provisions.

1. Obtaining and Processing of Personal Data, and Purposes of Processing:

Your personal data is collected and obtained verbally, in writing, or in visual or electronic media, through call center, internet site, verbally, in writing or similar other channels for conduct of such services as protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services offered by Acıbadem Group, or for planning and management of healthcare services and financing, and in accordance with the fields of business of Acıbadem Group Companies. Your general personal data and special personal data, especially your healthcare data, may be processed by the Group to a limited extent for all and any purposes, including, but not limited to, the following purposes:

All kinds of your personal data obtained by Acıbadem Group (including, but not limited to, your special personal data) may be processed for the following purposes:

Your personal data obtained and processed pursuant to the applicable laws and regulations may be transferred to physical archives and/or information systems of Acıbadem or Acıbadem Group and may be kept and stored both in digital and in physical platforms.

2. Transfer of Personal Data

Your personal data may be shared by Acıbadem and Acıbadem Group with companies included in Acıbadem Group or with private insurance companies, Ministry of Health and its sub-units, Social Security Agency, Security General Directorate and other security forces, General Directorate of Population and Census, Turkish Pharmacists’ Association, courts and all kinds of other juridical authorities, central etc. third parties, your authorized representatives and agents, and third parties offering consulting and advice services to us, including, but not limited to, lawyers, tax and financial consultants and auditors, and our business partners and other third parties acting in cooperation with us for further development or performance of healthcare services for the purposes cited above, also including regulatory and supervisory bodies and authorities, and official authorities, for the purposes of processing listed above, in accordance with the Law and other applicable laws and regulations.

3. Methods and Legal Causes of Obtaining of Personal Data

Your personal data are collected and processed in all kinds of verbal, written, visual or electronic media, for the purposes listed hereinabove, and for performance of all kinds of works included in the fields of business of Acıbadem within the legal framework, and accordingly, for full and proper performance of all kinds of contractual and legal duties and obligations of Acıbadem. Legal causes of collection and acquisition of your personal data are the pertinent provisions of:

Furthermore, as stipulated in 3rd paragraph of article 6 of the Law, personal data relating to health may also be processed by persons under secrecy obligations or by authorized official entities and organizations, without being liable to receive prior explicit consent of the relevant purpose, only for protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services, and for planning and management of healthcare services and financing.

4. Your Rights Regarding Protection of Personal Data

Pursuant to the Law and other relevant applicable laws and regulations, you are entitled:

If at any time you use any one or more of your aforesaid rights, the relevant information will be transmitted to you clearly and in an understandable manner, in writing or in electronic media, by using the communication data and information provided by you.

5. Data Security

Acıbadem protects your personal data in full and strict compliance with all technical and administrative security controls required to be taken in accordance with information security standards and procedures. Said security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

6. Complaints and Communications

Your personal data are protected within the frame of the available technical and administrative possibilities, and the required security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

By filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the , “https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html” web address, you may transmit and submit your legal requests:

You are hereby kindly requested to transmit your legal requests under the Law by filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html web address and sending it to us by the communication means set forth in the form.

TOP